PolyPid Hosts KOL Call to Discuss Significant Unmet Medical Need in Surgical Site Infections Prevention and Provides Update on its Ongoing SHIELD II Phase 3 Trial
Stock Information for PolyPid Ltd.
Loading
Please wait while we load your information from QuoteMedia.